Development of an ultrasensitive enzyme immunoassay for the determination of 
matrix metalloproteinase-9 (MMP-9) levels in normal human cerebrospinal fluid.

Maliszewska, M.; Mäder, M.; Schöll, U.; Azeh, I.; Hardeland, R.; Felgenhauer, K.; Beuche, W.; Weber, F.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Development of an ultrasensitive enzyme immunoassay for the determination of matrix metalloproteinase-9 (MMP-9) levels in normal human cerebrospinal fluid.

MPS-Authors

/persons/resource/persons80578

Weber, F.
AG Weber, Frank, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Maliszewska, M., Mäder, M., Schöll, U., Azeh, I., Hardeland, R., Felgenhauer, K., et al. (2001). Development of an ultrasensitive enzyme immunoassay for the determination of matrix metalloproteinase-9 (MMP-9) levels in normal human cerebrospinal fluid. Journal of Neuroimmunology, 116, 233-237.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-A330-4

Abstract

There is no abstract available